Background: Around 15% of clinically recognised pregnancies in women less than 35 years old result in spontaneous miscarriage. However recurrent pregnancy loss (RPL) is encountered in 5% of couples with two or more losses and in around 1–2% of couples with three or more losses. In view of the increasing burden of recurrent pregnancy loss in the society and in view of Anti-phospholipid syndrome being one of the undisputed treatable cause for recurrent pregnancy loss, this study aims to evaluate the significance of the antibody profiles of APS in relation to RPL in OBG dept of VIMS and RC.Methods: Patients coming to the Obstetric and Gynaecology department of Vydehi Institute of Medical Sciences and Research Centre, Bangalore, from December 1...
In order to determine the role of different anti-phospholipid antibodies as an etiologic factor in r...
AIM: The present study was aimed to define the incidence of antiphospholipid antibodies of different...
BACKGROUND: Antiphospholipid syndrome (APS) is a major reproductive complication in women, which is...
Background: Anticardiolipin antibodies (ACA) are found with increased prevalence in women with unexp...
Background: The management of patients with recurrent miscarriage (RM) and antiphospholipid antibody...
Background: Antiphospholipid syndrome is an autoimmune condition characterized by vascular thrombosi...
Background: Although women with antiphospholipid antibodies (APLAs) are at increased risk of recurre...
Background: The management of patients with recurrent miscarriage (RM) and antiphospholipid antibody...
BACKGROUND: Recurrent pregnancy loss (RPL) has been associated with antiphospholipid antibodies (APA...
Background: Recurrent miscarriage is a critical problem in which many factors play a crucial role su...
Background: Recurrent pregnancy loss is a heterogeneous reproductive problem, with multiple etiologi...
The present study was a prospective study aimed at screening for the presence of lupus anticoagulant...
Recurrent pregnancy loss, one of the crucial reproductive health concerns affecting 6% of couples. C...
BACKGROUND: Recurrent pregnancy loss (RPL) has been associated with antiphospholipid antibodies (APA...
Background: Recurrent miscarriage affects 1–2% of women. Recurrent pregnancy loss (RPL) is the loss ...
In order to determine the role of different anti-phospholipid antibodies as an etiologic factor in r...
AIM: The present study was aimed to define the incidence of antiphospholipid antibodies of different...
BACKGROUND: Antiphospholipid syndrome (APS) is a major reproductive complication in women, which is...
Background: Anticardiolipin antibodies (ACA) are found with increased prevalence in women with unexp...
Background: The management of patients with recurrent miscarriage (RM) and antiphospholipid antibody...
Background: Antiphospholipid syndrome is an autoimmune condition characterized by vascular thrombosi...
Background: Although women with antiphospholipid antibodies (APLAs) are at increased risk of recurre...
Background: The management of patients with recurrent miscarriage (RM) and antiphospholipid antibody...
BACKGROUND: Recurrent pregnancy loss (RPL) has been associated with antiphospholipid antibodies (APA...
Background: Recurrent miscarriage is a critical problem in which many factors play a crucial role su...
Background: Recurrent pregnancy loss is a heterogeneous reproductive problem, with multiple etiologi...
The present study was a prospective study aimed at screening for the presence of lupus anticoagulant...
Recurrent pregnancy loss, one of the crucial reproductive health concerns affecting 6% of couples. C...
BACKGROUND: Recurrent pregnancy loss (RPL) has been associated with antiphospholipid antibodies (APA...
Background: Recurrent miscarriage affects 1–2% of women. Recurrent pregnancy loss (RPL) is the loss ...
In order to determine the role of different anti-phospholipid antibodies as an etiologic factor in r...
AIM: The present study was aimed to define the incidence of antiphospholipid antibodies of different...
BACKGROUND: Antiphospholipid syndrome (APS) is a major reproductive complication in women, which is...